LincoRx 300 mg/mL

País: Austràlia

Idioma: anglès

Font: APVMA (Australian Pesticides and Veterinary Medicines Authority)

ingredients actius:

LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE

Disponible des:

PROBUS PHARMACEUTICALS PTY LTD

formulario farmacéutico:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composición:

LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE ANTIBIOTIC Active 300.0 mg/ml

Unidades en paquete:

100 mL

clase:

VM - Veterinary Medicine

Área terapéutica:

ANTIBIOTIC & RELATED

Resumen del producto:

Poison schedule: 4; Withholding period: WHP: MEAT: DO NOT USE less than 2 days b efore slaughter for human consumption. Any variation by the prescribing veterin arian to the approved dose, frequency, d uration, route, disease or host animal m ay result in the need to extend the regi stered withholding period ESI: EXPORT SLAUGHTER INTERVAL (ESI): An ESI has no t been established for this product. Not e- observing the meat withholding period may not be sufficient to mitigate the p otential risks to export trade. For advi ce on the ESI contact Probus Pharmaceuti cals Pty Ltd on 1800 940 556 or the APVM A website www.apvma.gov.au/residues.; Host/pest details: PIGS: [ARTHRITIS - INFECTIOUS, MYCOPLASMAL PNEUMONIA, ORGANISMS SENSITIVE TO LINCOMYCIN]

Estat d'Autorització:

Registered

Data d'autorització:

2023-07-01

Informació per a l'usuari

Product Name:
APVMA Approval No:
LincoRx 300
mg/mL
89477/124988
Label Name:
LincoRx 300
mg/mL
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
300 mg/mL LINCOMYCIN (as LINCOMYCIN HYDROCHLORIDE)
Claims:
For use by or under direction of a registered veterinarian
FOR INTRAMUSCULAR USE IN SWINE.
INDICATIONS
For the treatment of infections caused by micro-organisms sensitive to
lincomycin in swine.
Lincomycin is indicated for the treatment of infectious forms of
arthritis caused by
organisms sensitive to its activity. This includes most of the
organisms responsible
for the various infectious arthritides in swine such as the
Stapyhlococci, Streptococci,
Erysipelothrix and Mycoplasma spp.
Lincomycin is also indicated for the treatment of Mycoplasma
pneumonia.
Success in the treatment of viral diseases must be attributed to the
control of secondary
bacterial invaders rather than the effect of lincomycin on the virus.
Resistance may develop to any chemical.
Net Contents:
100 mL
Directions for Use:
Restraints:
Contraindications:
This product is contraindicated in animals previously found to be
hypersensitive to
Lincomycin.
This product is contraindicated for use in animals with known
pre-existing monilial
infections. RLP APPROVED
This product is contraindicated for use in rabbits, hamsters, guinea
pigs and horses as
these species are sensitive to the gastrointestinal effects. The
administration of this product
should be avoided in these species.
Precautions:
Side Effects:
Intramuscularly and intravenously, Lincomycin has demonstrated
excellent local tolerance
with no reports of pain of inflammation following injection.
The intramuscular administration to swine may cause a transient
diarrhea or loose stools.
Although this effect has rarely been reported, one must be alert to
the possibility that it may
occur. Should this occur, it is important that the necessary steps be
taken to prevent the
effects of dehydration.
The use of antibiotics occasionally